View of CLINICAL SIGNIFICANCE OF NOVEL BIOMOLECULES SUCH AS GALECTIN-3, APOPTOSIS-INDUCING FACTOR, ENDOTHELIN, AND VEGF-A IN THE DIAGNOSIS OF CHRONIC HEART FAILURE | World of Medicine and Biology

← CLINICAL SIGNIFICANCE OF NOVEL BIOMOLECULES SUCH AS GALECTIN-3, APOPTOSIS-INDUCING FACTOR, ENDOTHELIN, AND VEGF-A IN THE DIAGNOSIS OF CHRONIC HEART FAILURE